Viventis' patented light sheet microscopy enables researchers to study the development and dynamics of complex biological systems down to the level of individual cells in detail. As a particularly gentle imaging technique, light sheet microscopy provides an unbiased view of natural processes over time. The spatio-temporal resolution and image quality of the new Viventis LS2 Live light sheet fluorescence microscope enables researchers to expand their scientific understanding and analysis in biology, health and disease.
Viventis Microscopy started the development of light sheet microscopes in 2016 in collaboration with the laboratory of Prisca Liberali at the Friedrich Miescher Institute, Basel, Switzerland. Since then, the company has provided microscopes to top European research institutes. The startup has joined the Leica Microsystems family, where it will continue to advance its technology.
Petr Strnad, co-founder of Viventis Microscopy and now part of the Leica Microsystems Life Sciences Business Unit, is very excited about this transition and adds, "Leica Microsystems was the ideal partner for us to ensure access to innovative light sheet solutions for the global research community. Now that we are part of the Leica team, we will continue to help researchers embark on a new journey of breakthrough scientific discoveries.”
"At Leica Microsystems, our focus in life sciences is on delivering the context required by researchers to enable tomorrow's breakthroughs," said Dr. Annette Rinck, President of Leica Microsystems. "With Viventis Microscopy joining our strong portfolio, we will empower the global research community to extract this context from 3D models such as organoids and other large samples. Indeed, the gentle visualization of the entire sample volume in organoids with unprecedented detail over time is transforming in-depth functional studies and pushing the boundaries of scientific understanding."
(Press release / SR)
Image: ©Leica Microsystems
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
Please login or sign up to comment.
Commenting guidelines